Gene therapy of malignant gliomas: A phase I study of IL-4-HSV-TK gene- modified autologous tumor to elicit an immune response

Hideho Okada, Ian F. Pollack, Michael T. Lotze, L. Dade Lunsford, Douglas Kondziolka, Frank Lieberman, David Schiff, Jason Attanucci, Howard Edington, William Chambers, Paul Robbins, Joe Baar, Donna Kinzler, Theresa Whiteside, Elaine Elder

Research output: Contribution to journal › Comment/debate › peer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Gene therapy of malignant gliomas: A phase I study of IL-4-HSV-TK gene- modified autologous tumor to elicit an immune response'. Together they form a unique fingerprint.